BRANFORD, Conn., May 22 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. , a medical device company focused on innovative, non-invasive vital signs monitoring, today announced that it will be introducing its line of LIFEGARD Patient Monitors, co-branded with Analogic Corporation, at the National Teaching Institute & Critical Care Exposition (NTI) in Atlanta, GA this week. NTI is the premier educational conference for nurses caring for acutely and critically ill patients. In conjunction with the introduction, CASMED is launching its updated corporate website later this week.
Earlier this month, CASMED announced its agreement with Analogic Corporation under which CASMED will act as the exclusive worldwide distributor for the LIFEGARD family of patient monitors. Andrew E. Kersey, President and Chief Executive Officer of CASMED, remarked, “We are pleased to have rapidly put into place the tools and materials needed to launch the LIFEGARD monitors at the NTI. The NTI brings together key influencers and decision makers in the critical care arena and is an ideal platform for the product line introduction.”
In conjunction with the launch of the LIFEGARD product line, CASMED will be rolling out its redesigned website: www.casmed.com. The new site has been streamlined to reflect the CASMED brand identity and latest product introductions, including both the FORE-SIGHT(TM) Absolute Cerebral Oximeter and the LIFEGARD monitors. Complete product listings and support materials, as well as easy access to investor and customer care information, will be available in a user-friendly format. “This new website reflects our dedication to enhancing communication with our customers and other important stakeholders. This platform will continue to be updated with new products and information as they become available,” stated Mr. Kersey.
About CASMED
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative, non-invasive technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include cerebral oximeters, blood pressure measurement technology, vital signs monitors, blood pressure cuffs, cardio-respiratory and apnea monitors and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For further information regarding CAS Medical Systems, Inc., visit the Company’s website at www.casmed.com.
For more information on the LIFEGARD product line, please contact: Sales & Marketing SalesMktg@casmed.com Company Contacts CAS Medical Systems, Inc. Jeffery Baird, CFO 203-488-6056 ir@casmed.com Investors and Media FD John Capodanno 212-850-5705 jcapodanno@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s most recent Form 10-KSB and other Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate”, “believe”, “estimate”, “expect”, “may”, “objective”, “plan”, “possible”, “potential”, “project”, “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc.
CONTACT: Jeffery Baird, CFO of CAS Medical Systems, Inc., +1-203-488-6056,ir@casmed.com; or Investors and Media, John Capodanno of FD,+1-212-850-5705, jcapodanno@fd-us.com, for CAS Medical Systems, Inc.
Web site: http://www.casmed.com//
